No series here
Try another search?
Is there a role for fondaparinux in perioperative bridging? Author Candice Garwood discusses with Lori Justice, Associate Editor for AJHP, issues surrounding the use of fondaparinux as a bridging agent in the perioperative setting. The article under discussion appears in the January 1, 2011, issue of AJHP, and will also appear as an Ahead-of-Pr ...…
SAEM 2007 Satellite Symposium: Controversies in Emergency Cardiology, Round II
CEC debate on the efficacy, safety, and utility of fondaparinux versus LMWH compared with that of bivalirudin: Moderator: W. Frank Peacock IV, MD; Debaters: Chadwick D. Miller, MD versus Deborah B. Diercks, MD, FACEP.
CTR.org Ask the Experts program, a presentation by Ron J. G. Peters, MD regarding the efficacy and safety of fondaparinux in elderly patients with STEMI: data from the OASIS 6 trial.
CTR Ask the Experts program, a presentation by C. Michael Gibson, MS, MD: The OASIS 5 and ACUITY clinical trials. Dr. Gibson presents the results from the OASIS V and ACUITY trials. Efficacy and safety data are presented for fondaparinux versus enoxaparin and for enoxaparin versus bivalirudin.
CEC Debate on the efficacy, safety and utility of fondaparinux versus LMWH: Moderator: James Hoekstra MD; Debaters: Charles V. Pollack Jr. MA MD versus Judd Hollander MD.